Serum visfatin in type 2 diabetes mellitus

• Glavni autori: Samiha A. Abd Rabo (Autor), Nagwa A. Mohammed (Autor), Somayh S. Eissa (Autor), Abeer A. Ali (Autor), Sahar M. Ismail (Autor), Reham S. Gad (Autor)
• Format: Knjiga
• Izdano: SpringerOpen, 2013-01-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

IntroductionObesity is commonly associated with insulin resistance and hyperinsulinemia and is the most important risk factor for type 2 diabetes. Visfatin is an adipokine that exerts insulin-mimetic effects that stimulate muscle and adipocyte glucose transport and inhibit hepatocyte glucose product...